Evidence map›Paper›PMID 23172989›Full record

ReviewVascular health and risk management2012

Treatment of prehypertension: lifestyle and/or medication.

Scott R Collier, Michael J Landram

Registry-linked trialAbstract readReview
In one paragraph

Review in Vascular health and risk management, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03764020 (A Triple Blinded Randomized Controlled Trial of Oral Melatonin in Elevated Blood Pressure Individual), which is not on this map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03764020 phase3unknown statusnot on this mapstarted 2019, after this paper: background citation

A Triple Blinded Randomized Controlled Trial of Oral Melatonin in Elevated Blood Pressure Individual (MRCTEBP)

TypeinterventionalSponsorTehran University of Medical SciencesRan2019 to 2019Enrolled320ConditionsElevated Blood PressureArmsPlacebo oral capsule/placebo comparator, Melatonin/experimental
3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Hypertensive patients' knowledge and practices on lifestyle modification in Extension 6, Middelburg.South African family practice : official journal of the South African Academy of Family Practice/Primary Care · 2022
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Scott R CollierVascular Biology and Autonomic Studies Laboratory, Appalachian State University, Boone, NC, USA. colliersr@appstate.edu
Michael J Landram

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Prehypertension is a warning to individuals with resting blood pressures between 120/80 mmHg and 139/89 mmHg of an insidious progression of blood pressure towards hypertensive levels (≥ 140/90 mmHg). Prehypertension is associated with increased cardiovascular risk and end organ damage compared with individuals who are normotensive. This review primarily focuses on internal and external factors associated with the prevalence of prehypertension. Elucidating all of the factors associated with a rise in resting blood pressure and comparing the effects of medication versus lifestyle changes may aid the clinician in developing a preventive and/or treatment strategy for each individual.

Indexed as

Risk Reduction BehaviorAntihypertensive AgentsBlood PressureHumansPrehypertensionPrevalenceRisk AssessmentRisk FactorsTreatment OutcomeAntihypertensive Agentsblood pressurelifestyle changessex differences

Identifiers

PMID23172989
PMCPMC3502030

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.